Review

IMMUNOTHERAPY STRATEGIES FOR

Artur Marcysiak Patrycja Mularczyk Nina Polek M. Sikorska Wojciech Łysoniewski Tomasz Mruzek Magdalena Kiełbasiewicz Karolina Zawadzka Aleksandra Marcysiak

· 1 citation · 69 references

TL;DR

This review aims to discuss current and emerging treatment approaches based on modulation of the immune response, with particular emphasis on immune checkpoint inhibitors, targeted therapies, and mRNA vaccines.

Semantic Scholar

View source

Similar papers

Review Open access Sep 2026

NEW IMMUNOTHERAPY STRATEGIES FOR MELANOMA: CHECKPOINT INHIBITORS, COMBINATION THERAPIES AND mRNA VACCINES

Current and emerging treatment approaches based on modulation of the immune response, with particular emphasis on immune checkpoint inhibitors, targeted therapies, and mRNA vaccines are discussed.

Artur Marcysiak, Patrycja Mularczyk, Nina Polek et al. · International Journal of Inn... · 0 citations

Review Open access Sep 2026

Efficacy and Safety of Immunotherapeutic Strategies for the Treatment of MART-1-Expressing Melanoma: Systematic Review of Clinical Trials

Simple Summary Immunotherapy has become an important treatment strategy for patients with advanced melanoma. Melanoma antigen recognized by T cells 1 (MART-1) has been extensively investigated as a target for a variety of immunotherapeutic approaches, including DNA- and peptide-based vaccines, adoptive cell therapies,...

A. Alshevskaya, Sofya Tsarikova, E. Golikova et al. · Cancers · 0 citations

Review Open access Sep 2026

Recent advances in targeted therapies and immunotherapies for triple-negative breast cancer

This comprehensive review explores advancements in the treatment of Triple-Negative Breast Cancer (TNBC), emphasizing the transformative impact of targeted therapies and immunotherapies. Given TNBC’s aggressive nature and limited therapeutic options, this review provides an in-depth analysis of emerging strategies that...

Gowhar Rashid, D. Elsori, Zainab Naqvi et al. · Frontiers in Oncology · 0 citations

Review Sep 2026

Recent Advances in Tumor-Infiltrating Lymphocyte Therapy for Melanoma

Overall, TIL therapy constitutes a rapidly evolving and clinically potent treatment modality for melanoma and covers recent advances for improving therapeutic outcomes, including safety optimization, product optimization, next-generation engineered TILs, and predictive biomarkers.

H. Zeng, Wu-Xuan Mei, Chang-Chun Zeng · Current Treatment Options in... · 0 citations

Review Open access Oct 2026

Immunotherapy in Glioblastoma: Why Has Progress Been so Difficult?

Glioblastoma remains one of the most aggressive and difficult-to-treat brain tumors. Although immunotherapy has transformed the management of several cancers, its clinical impact in glioblastoma has been limited. This review summarizes the main immunotherapeutic approaches currently investigated, including immune check...

D. Slavkov, S. Troyanova-Slavkova · Cancer Immunology Connect · 0 citations

Review Open access

Novel immunotherapeutic strategies for multiple myeloma

Outline and aim of this thesis In this thesis, we investigated the determinants of response and resistance to currently used immunotherapy-based regimens in multiple myeloma. We also evaluated novel immunotherapies, including T-cell redirecting therapies and cereblon E3 ligase modulators, in both preclinical and clini...

C. Korst · 0 citations